Receptive Bio

Company developing targeted gene delivery solutions

placeLos Angeles, California, United States calendar_todayFounded 2024 language receptivebio.com

Innovation

1 patent family — focus: Human necessities; filing pace active.

YearFilings
20261

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon